San Jiun Chai

Title: The Innovative Contributions of San Jiun Chai

Introduction: San Jiun Chai is a notable inventor based in Selangor, Malaysia. He has made significant strides in the field of immunology, particularly in developing peptide compositions aimed at inducing anti-cancer immune responses. His work is crucial in the ongoing battle against cancer, showcasing the potential of innovative therapies.

Latest Patents: San Jiun Chai holds a patent for an immunogenic peptide composition. This invention relates to a peptide composition capable of binding with major histocompatibility complex class I molecules to induce an anti-cancer immune response in a subject. The peptide composition comprises at least a Four-jointed Box 1 peptide and a Melanoma Antigen family D4b peptide. Furthermore, the invention includes the use of this peptide composition and a peptide vaccine for inducing the anti-cancer immune response in the subject. He has 1 patent to his name.

Career Highlights: San Jiun Chai is currently associated with Cancer Research Malaysia, where he contributes to groundbreaking research in cancer treatment. His work is instrumental in advancing the understanding of immune responses to cancer, paving the way for new therapeutic strategies.

Collaborations: San Jiun Chai collaborates with esteemed colleagues, including Sammuel Chee Yong Fong and Sok Ching Cheong. Their collective efforts enhance the research output and innovation at Cancer Research Malaysia.

Conclusion: San Jiun Chai's contributions to immunology and cancer research exemplify the impact of innovative thinking in medicine. His patent for an immunogenic peptide composition represents a significant advancement in cancer treatment strategies.